CMPX - Compass Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.34 0.54 (12.44%)	0.0 (0.0%)	0.0 (0.0%)	0.08 (1.68%)	-0.03 (-0.78%)	0.43 (9.91%)	0.08 (1.66%)	0.08 (1.66%)

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.14
Diluted EPS:
Basic P/E:: -34.8564
Diluted P/E:
RSI(14) 1m:: 100.0
VWAP:: 4.88
RVol:: 1.078

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	4.76 +0.06 (+1.28%)	Oct 15 15:56
Day	Price increase day	4.78 +0.44 (+10.02%)	Oct 15 12:28
1m	Price decrease 1m	4.65 -0.05 (-1.06%)	Oct 15 11:33